Metrics for Biotechnology (Nasdaq NBI) 2x
You end 10% ahead of 1x, and at worst you were 34% behind.
Cumulative edge of the leveraged product in this period · 0% = same as 1x
Provisional thresholds: rough stretch if it was more than 20% behind or behind for more than 3 years.
More metrics
| Metric | Leveraged | 1x |
|---|---|---|
| Volatility | 46.8% | 23.4% |
| Sharpe | 0.43 | 0.47 |
| Sortino | 0.62 | 0.68 |
| Calmar | 0.19 | 0.30 |
| Ulcer | 35.2 | 14.9 |
| Positive years | 50% | 70% |
| Best year | +59% (2025) | +33% |
Volatility measures a normal year; it misses the extreme drops (see the max drawdown). Sharpe and Sortino use the short-term rate of the currency shown.
Keep in mind
- Series simulated with the study's model (same cost calibration for every index): not the price of a specific ETF.